Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
DtQg8DyEUFN7VbfG